In Albany, N.Y., the New York State Office of Cannabis Management has announced a pivotal shift from BioTrack to Metrc as its primary Seed-to-Sale tracking system, targeting a go-live in early 2026. This move aims to fortify regulatory compliance in the state's rapidly expanding cannabis industry, ensuring safer products and tighter controls from cultivation to consumer sales.
Understanding Seed-to-Sale and the Switch Rationale
Seed-to-Sale systems trace cannabis plants from planting through harvest, processing, testing, packaging, and retail sale, preventing diversion to black markets and verifying product safety. New York's Office of Cannabis Management conducted a thorough assessment of BioTrack and Metrc, concluding that Metrc better serves the state's interests amid booming legal sales—over $500 million in 2023 alone. The transition reflects broader trends in cannabis regulation post-2021 legalization, where states prioritize robust tech to match market growth and public health demands.
Key Operational Details for Licensees
Licensees must adapt swiftly while maintaining compliance. The agency outlines clear steps:
- Log out of BioTrack NY to halt API data flow.
- Continue real-time electronic inventory tracking.
- Preserve all historical data locally.
- Use paper manifests for inter-licensee transfers.
- Submit reports via the existing portal.
- Provide records on request.
Labs must transmit testing data to Metrc, with costs limited to $0.10 per unique identifier—plant and package tags provided free. Third-party integrators transition at no extra charge, easing the burden on New York's 1,000+ licensees.
Guidelines for Cultivators and Future Roadmap
For cultivators, immature plants can be batched by strain (up to 100 per batch) with a unique identifier before vegging, recording essentials like location, planting date, count, and cultivar. Tags must remain visible and clean. This flexibility acknowledges high early-stage losses while upholding traceability.
Looking ahead, the agency is finalizing timelines, test environments, and integrations, promising updates soon. This upgrade could reduce compliance errors—common in BioTrack transitions elsewhere—and enhance consumer trust in a market projected to hit $2 billion annually by 2027, aligning New York with leading states like California and Colorado for safer, more transparent cannabis ecosystems.
